ASCEND BY NTHRYS
Research Abroad Products

Molecular Diagnostics Project Topics

Browse all focused areas across all project categories under this field.

Showing 37–48 of 200 project topics
White-Label Molecular Testing Platform for Regional Laboratories
Turnkey diagnostic infrastructure allowing smaller clinical laboratories to offer comprehensive oncology panels without capital equipment investment. Generates high-margin recurring revenue through per-test fees while establishing strategic partnerships with regional healthcare networks.
Molecular Oncology Companion Diagnostic Dev Click to view more details →
Hereditary Cancer Risk Stratification Analytics Software
Clinical decision support tool interpreting germline mutations in BRCA1, BRCA2, and other cancer predisposition genes with actionable recommendations. Expands preventive oncology market opportunities through direct-to-consumer testing partnerships and oncologist subscriptions.
Molecular Oncology Companion Diagnostic Dev Click to view more details →
Multi-Gene Resistance Mutation Detection High-Throughput Platform
Multiplexed diagnostic assay identifying acquired therapy-resistance mutations across common oncogenes to guide treatment switching decisions. Enables pharma companies to develop reflex testing partnerships, expanding market access and creating locked-in repeat testing cycles.
Molecular Oncology Companion Diagnostic Dev Click to view more details →
Customizable Cancer Panel Design and Deployment Service
Modular diagnostics platform allowing pharmaceutical companies to co-develop cancer-specific gene panels paired with their targeted therapies. Generates co-development fees, royalties on companion diagnostic sales, and strengthens drug market exclusivity through diagnostic-therapeutic bundling.
Molecular Oncology Companion Diagnostic Dev Click to view more details →
CRISPR-Based Pathogen Detection SaaS Platform
A cloud-based software platform that integrates CRISPR-Cas13 detection assays with real-time data analytics for rapid identification of viral, bacterial, and fungal pathogens in clinical samples. This platform enables diagnostic laboratories and hospitals to reduce turnaround time from hours to minutes while charging per-test subscription fees and licensing enterprise accounts.
CRISPR-Based Molecular Diagnostic Development Click to view more details →
CRISPR Point-of-Care Diagnostic Device Manufacturing
A commercial product line of portable, lab-independent CRISPR diagnostic devices designed for point-of-care testing in clinics, pharmacies, and field settings. Revenue streams include device hardware sales, disposable cartridge subscriptions, and partnership licensing with healthcare providers seeking to decentralize diagnostics.
CRISPR-Based Molecular Diagnostic Development Click to view more details →
Multiplexed CRISPR Assay Development as Service
A contract research service that designs and validates custom multiplexed CRISPR diagnostic assays targeting multiple biomarkers or pathogens simultaneously for pharmaceutical and diagnostic companies. This service generates recurring revenue through assay development fees, validation protocols, and ongoing technical support contracts.
CRISPR-Based Molecular Diagnostic Development Click to view more details →
CRISPR Diagnostic Reagent Kit Commercial Distribution
A commercial product offering pre-optimized, ready-to-use CRISPR detection reagent kits for infectious disease testing, genetic screening, and oncology diagnostics sold directly to clinical laboratories and research institutions. Revenue is generated through high-margin unit sales, volume-based tiered pricing, and exclusive distribution partnerships.
CRISPR-Based Molecular Diagnostic Development Click to view more details →
AI-Powered CRISPR Signal Analysis Software Tool
An artificial intelligence software tool that enhances CRISPR diagnostic accuracy by automating signal interpretation, reducing false positives, and enabling interpretation of complex multiplex results in real-time. This tool creates value through software licensing fees, per-analysis charges, and integration partnerships with existing diagnostic platforms.
CRISPR-Based Molecular Diagnostic Development Click to view more details →
CRISPR Diagnostics Quality Control Certification Service
A specialized compliance and quality assurance service that certifies CRISPR diagnostic assays and platforms meet regulatory standards including CLIA, CAP, and FDA requirements for clinical use. Revenue is derived from certification audit fees, ongoing compliance monitoring subscriptions, and regulatory documentation services.
CRISPR-Based Molecular Diagnostic Development Click to view more details →
High-Throughput CRISPR Screening Platform for Biomarkers
A commercial high-throughput screening platform using CRISPR technology to identify novel disease biomarkers and diagnostic targets for pharmaceutical and biotech clients. This platform monetizes through per-screen project fees, data licensing agreements, and biomarker discovery partnerships with major pharmaceutical companies.
CRISPR-Based Molecular Diagnostic Development Click to view more details →
CRISPR Diagnostic Laboratory Information Management System
A specialized Laboratory Information Management System (LIMS) software designed to integrate, track, and report CRISPR diagnostic test results with automated quality metrics and patient data management. The platform generates recurring SaaS revenue through monthly subscriptions, per-test processing fees, and integration services.
CRISPR-Based Molecular Diagnostic Development Click to view more details →